Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2444 USD | -2.32% | +1.83% | -86.57% |
Apr. 15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Apr. 12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.95M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -16M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.09
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.18% |
1 day | -6.08% | ||
1 week | +1.83% | ||
Current month | -56.61% | ||
1 month | -49.40% | ||
3 months | -71.25% | ||
6 months | -87.00% | ||
Current year | -86.57% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Walters
CEO | Chief Executive Officer | 57 | 16-07-31 |
Allan Shaw
DFI | Director of Finance/CFO | 59 | 20-05-11 |
Steve Innaimo
COO | Chief Operating Officer | - | 19-01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Bailey
FOU | Founder | 68 | 72-12-31 |
Steven Mintz
BRD | Director/Board Member | 57 | 16-04-05 |
Robert Glassman
BRD | Director/Board Member | 62 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.2444 | -2.32% | 34 690 |
24-04-24 | 0.2502 | +3.13% | 187,060 |
24-04-23 | 0.2426 | -18.37% | 169,111 |
24-04-22 | 0.2972 | +9.67% | 430,127 |
24-04-19 | 0.271 | +12.92% | 300,411 |
Delayed Quote Nasdaq, April 25, 2024 at 12:03 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.57% | 4.95M | |
+0.76% | 43.84B | |
+5.49% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.45% | 25.53B | |
-25.48% | 18.18B | |
-3.14% | 12.29B | |
+25.89% | 12.29B | |
+6.88% | 11.15B |
- Stock Market
- Equities
- PRTG Stock